Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-136180

Published: 2020

Journal Articles

Impact of Amotosalen/UVA Pathogen Inactivated Platelet Components on Outcomes after Allogeneic Hematopoetic Stem Cell Transplantation: A Single Center Analysis

Andreas S. Buser, MD, Laura Infanti, MD, Andreas Holbro, MD, Joerg Halter, MD, Sabine Gerull, MD, Dominik Heim, MD, Michael Medinger, MD, Dimitrios A. Tsakiris, MD, Johannes Irsch, PhD, Jin-Sying Lin, PhD, Richard J. Benjamin, MD, Laurence Corash, MD, Jakob R. Passweg, MD

Blood (2019) 134 (Supplement_1): 1167.

https://doi.org/10.1182/blood-2019-122330

Published: 2019

Journal Articles

Red Blood Cell Allo-Antibodies after Allogeneic Hematopoietic Stem Cell Transplantation

Astrid Beerlage, MD, Joerg Halter, MD, Sabine Gerull, MD, Michael Medinger, MD, Tanja Ruefli, Georg Stussi, MD, Dominik Heim, MD, Beatrice Drexler, MD, Laura Infanti, MD, Andreas Holbro, MD, Jakob R. Passweg, MDMS, Andreas S. Buser, MD

Blood (2018) 132 (Supplement 1): 2551.

https://doi.org/10.1182/blood-2018-99-116237

Published: 2018

Journal Articles

Targeting Cell Non-Autonomous MAPK Activation As a Novel Therapeutic Strategy in Myeloproliferative Neoplasms

Sara C. Meyer, MD PhD, Nilabh Ghosh, MSc, Simona Stivala, PhD, Anne Baerenwaldt, PhD, Hui Hao-Shen, Stefan Dirnhofer, MD, Matthias S. Dettmer, MD, Cédric Simillion, PhD, Sophia Chiu, MSc, Matthew Keller, MSc, Maria Kleppe, PhD, Morgane Hilpert, PhD, Andreas S. Buser, MD, Jakob R. Passweg, MDMS, Thomas Radimerski, PhD, Radek C. Skoda, MD, Ross L. Levine, MD

Blood (2017) 130 (Supplement 1): 381.

https://doi.org/10.1182/blood.V130.Suppl_1.381.381

Published: 2017

Journal Articles

The Intercept Blood System Affects Platelet Function and Survival By Inducing Apoptosis

Simona Stivala, PhD, Sara Gobbato, M.Sc., Martin F Reiner, MD, Sara C Meyer, MDPhD, Thomas F Lüscher, MD, Laura Infanti, Andreas S. Buser, MD, Juerg H. Beer, MD

Blood (2014) 124 (21): 4283.

https://doi.org/10.1182/blood.V124.21.4283.4283

Published: 2014

Journal Articles

Evaluation Of The Pre-Transplantation Workup Before Allogeneic Transplantation and Reasons For Delaying Or Cancelling Transplant

Sabine Gerull, MD, Andreas S Buser, MD, Christoph Bucher, MD, Dominik Heim, MD, Michael Medinger, MD, Jakob Passweg, MD, Martin Stern, MD

Blood (2013) 122 (21): 5456.

https://doi.org/10.1182/blood.V122.21.5456.5456

Published: 2013

Journal Articles

Addition of Omega-3 α-Linolenic Acid to Platelet Apheresis Units Preserves Platelet Activatability Over Time and Reduces Baseline Activation Under Routine Storage Conditions: A Pilot Study

Simona Stivala, Ph.D., Sara C Meyer, MD PhD, Martin Reiner, MD, Thomas F. Luscher, MD, Andreas S. Buser, MD, Juerg H. Beer, MD

Blood (2012) 120 (21): 3433.

https://doi.org/10.1182/blood.V120.21.3433.3433

Published: 2012

Journal Articles

Prognostic Impact of Iron Overload During Follow-up After Allogeneic Stem Cell Transplantation

Sara C. Meyer, MD, PhD, Andreas S. Buser, MD, André Tichelli, MD, Jakob R. Passweg, MD, Martin Stern, MD

Blood (2011) 118 (21): 347.

https://doi.org/10.1182/blood.V118.21.347.347

Published: 2011

Journal Articles

Transfusion of Cryopreserved Autologous Platelets to Overcome HLA Alloimmunization in Patients with Hematological Malignancies,

Bernhard Gerber, MD, Lorenzo Alberio, MD, Frank Stenner, MD, Andreas S. Buser, MD, Urs Schanz, MD, Georg Stussi, MD

Blood (2011) 118 (21): 3375.

https://doi.org/10.1182/blood.V118.21.3375.3375

Published: 2011

Journal Articles

Prognostic Impact of Different Iron Parameters In Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Godwin Nosakhare Bazuave, MD, Andreas S. Buser, MD, Sabine Gerull, MD, André Tichelli, MD, Martin Stern, MD

Blood (2010) 116 (21): 168.

https://doi.org/10.1182/blood.V116.21.168.168

Published: 2010

Journal Articles

The Value of Routine Ferritin Measurement In Blood Donors

Alix O'Meara, Laura Infanti, Jörg Sigle, Martin Stern, Andreas S. Buser, MD

Blood (2010) 116 (21): 3353.

https://doi.org/10.1182/blood.V116.21.3353.3353

Published: 2010

Journal Articles

The Bidirectional Relationship Between Cytomegalovirus Replication and Graft-Versus-Host Disease - a Retrospective Single Center Study.

Nathan Cantoni, Hans H Hirsch, Nina Khanna, Dominik Heim, Joerg Halter, Dimitrios Tsakiris, Christoph Bucher, Alicia Rovò, Caroline Arber, MD, Andreas S Buser, Andre Tichelli, Alois Gratwohl, Martin Stern

Blood (2009) 114 (22): 2236.

https://doi.org/10.1182/blood.V114.22.2236.2236

Published: 2009

Journal Articles

Cyclophosphamide-Busulfan Instead of Busulfan-Cyclophosphamide for Conditioning in Allogeneic Hematopoietic Stem Cell Transplantation.

Nathan Cantoni, Sabine Gerull, Dominik Heim, Joerg Halter, Dimitrios Tsakiris, Christoph Bucher, Alicia Rovo, Caroline Arber, Andreas S. Buser, Jakob R. Passweg, Andre Tichelli, Martin Stern, Alois Gratwohl

Blood (2009) 114 (22): 2268.

https://doi.org/10.1182/blood.V114.22.2268.2268

Published: 2009

Journal Articles

The JAK2-V617F Mutation Load Remains Stable over Several Years in Most Patients with Myeloproliferative Disorders Analyzed in a Retrospective Single Center Study.

Alexandre Theocharides, MD, Renate Looser, Hao-Shen Hui, Andreas S. Buser, MD, Alois Gratwohl, MD, Andre Tichelli, MD, Radek C. Skoda, MD

Blood (2007) 110 (11): 2526.

https://doi.org/10.1182/blood.V110.11.2526.2526

Published: 2007

Journal Articles

High Dose Chemotherapy Using Beam without Autologous Rescue Followed by Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Refractory or Relapsing Lymphomas - A Comparison of Delayed Versus Immediate Transplantation.

Andreas S. Buser, MD, Martin Stern, MD, Christoph Bucher, MD, Caroline Arber, MD, Dominik Heim, MD, Joerg Halter, MD, Sandrine Meyer-Monard, MD, Georg Stussi, MD, Andreas Lohri, MD, Michele Ghielmini, MD, Andre Tichelli, MD, Jakob R. Passweg, MD, Alois Gratwohl, MD

Blood (2006) 108 (11): 5352.

https://doi.org/10.1182/blood.V108.11.5352.5352

Published: 2006

Journal Articles

Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders

Robert Kralovics, Soon-Siong Teo, Sai Li, Alexandre Theocharides, Andreas S. Buser, Andre Tichelli, Radek C. Skoda

Blood (2006) 108 (4): 1377–1380.

https://doi.org/10.1182/blood-2005-11-009605

Published: 2006

Includes: Supplemental data

Journal Articles

Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2

Robert Kralovics, Soon-Siong Teo, Andreas S. Buser, Martin Brutsche, Ralph Tiedt, Andre Tichelli, Francesco Passamonti, Daniela Pietra, Mario Cazzola, Radek C. Skoda

Blood (2005) 106 (10): 3374–3376.

https://doi.org/10.1182/blood-2005-05-1889

Published: 2005

Includes: Supplemental data

Journal Articles

Gene Expression Profiling Defines a Set of New Molecular Markers for Sporadic and Familial Myeloproliferative Disorders.

Robert Kralovics, PhD, Soon-Siong Teo, Francesco Passamonti, Andreas S. Buser, MD, Andre Tichelli, MD, Mario Cazzola, MD, Radek C. Skoda, MD

Blood (2004) 104 (11): 657.

https://doi.org/10.1182/blood.V104.11.657.657

Published: 2004

Journal Articles

Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders

Robert Kralovics, Andreas S. Buser, Soon-Siong Teo, Jörn Coers, Andre Tichelli, Anthonie P. C. van der Maas, Radek C. Skoda

Blood (2003) 102 (5): 1869–1871.

https://doi.org/10.1182/blood-2003-03-0744

Published: 2003

NARROW

Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study

Impact of Amotosalen/UVA Pathogen Inactivated Platelet Components on Outcomes after Allogeneic Hematopoetic Stem Cell Transplantation: A Single Center Analysis

Red Blood Cell Allo-Antibodies after Allogeneic Hematopoietic Stem Cell Transplantation

Targeting Cell Non-Autonomous MAPK Activation As a Novel Therapeutic Strategy in Myeloproliferative Neoplasms

The Intercept Blood System Affects Platelet Function and Survival By Inducing Apoptosis

Evaluation Of The Pre-Transplantation Workup Before Allogeneic Transplantation and Reasons For Delaying Or Cancelling Transplant

Addition of Omega-3 α-Linolenic Acid to Platelet Apheresis Units Preserves Platelet Activatability Over Time and Reduces Baseline Activation Under Routine Storage Conditions: A Pilot Study

Prognostic Impact of Iron Overload During Follow-up After Allogeneic Stem Cell Transplantation

Transfusion of Cryopreserved Autologous Platelets to Overcome HLA Alloimmunization in Patients with Hematological Malignancies,

Prognostic Impact of Different Iron Parameters In Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

The Value of Routine Ferritin Measurement In Blood Donors

The Bidirectional Relationship Between Cytomegalovirus Replication and Graft-Versus-Host Disease - a Retrospective Single Center Study.

Cyclophosphamide-Busulfan Instead of Busulfan-Cyclophosphamide for Conditioning in Allogeneic Hematopoietic Stem Cell Transplantation.

The JAK2-V617F Mutation Load Remains Stable over Several Years in Most Patients with Myeloproliferative Disorders Analyzed in a Retrospective Single Center Study.

High Dose Chemotherapy Using Beam without Autologous Rescue Followed by Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Refractory or Relapsing Lymphomas - A Comparison of Delayed Versus Immediate Transplantation.

Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders

Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2

Gene Expression Profiling Defines a Set of New Molecular Markers for Sporadic and Familial Myeloproliferative Disorders.

Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only